Phase II Study of Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors.

Trial Profile

Phase II Study of Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Doxorubicin (Primary) ; Fluorouracil (Primary) ; Streptozocin (Primary)
  • Indications Endocrine gland neoplasms; Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Aug 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 09 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top